KATIE NACPIL: Open Payments
NPI 1184267221 · FORT WORTH, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$967 in 47 payments from 17 companies in 2025. Trend: 2023 $195 · 2024 $1,572 · 2025 $967
Food & beverage: $967
| Company | Payments | Amount |
|---|---|---|
| Sumitomo Pharma America, Inc. | 12 | $177 |
| Boston Scientific Corporation | 2 | $131 |
| Verity Pharmaceuticals Inc. | 7 | $111 |
| UROGEN PHARMA, INC. | 4 | $111 |
| Antares Pharma, Inc. | 4 | $64 |
| 180 Medical, Inc. | 3 | $59 |
| Endo USA, Inc. | 2 | $45 |
| Olympus America Inc. | 2 | $42 |
| BLUEWIND MEDICAL | 2 | $40 |
| TOLMAR, INC. | 2 | $35 |
Products named: Bulkamid, Trelstar, GEMTESA, ORGOVYX, XYOSTED, ZUSDURI, AVEED, iTIND System.
Industry payments across TX — which companies pay providers there.
